British drugmaker confirms guidance for year in which it will spin-off its consumer goods division
Limited efficacy means it is increasingly seen as a therapy for those who cannot take rival medications
Government agrees supply deal with GSK for injectable drug sotrovimab
Sotrovimab is effective against all 37 identified mutations in the spike protein, GSK says
Britain’s drug regulator has approved Xevudy treatment
Drug to be assessed for ability to stave off infections for up to a year in some people
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices